These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6229379)

  • 41. Insulin-like growth factor-1 and cardiac mass in essential hypertension: comparative effects of captopril, lisinopril and quinapril.
    Díez J; Laviades C
    J Hypertens Suppl; 1994 Jul; 12(4):S31-6. PubMed ID: 7965272
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Validity of the ECG diagnosis of left ventricular hypertrophy in normotensive and moderately hypertensive men when using the echocardiographic assessment of left ventricular mass index as reference.
    Otterstad JE; Froeland G; Wasenius AK; Knutsen KM; Michelsen S; Stugaard M
    J Hum Hypertens; 1991 Apr; 5(2):101-6. PubMed ID: 1830106
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Captopril versus enalapril maleate: a comparison of antihypertensive and hormonal effects.
    Lewis RA; Baker KM; Ayers CR; Weaver BA; Lehman MR
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S12-5. PubMed ID: 2580164
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of left ventricular hypertrophy in hypertensive patients with a combination of verapamil and captopril--a multicenter study.
    Magometschnigg D; Brandt D; Hofmann R; Sihorsch K; Stoschitzky K; Zangeneh M; Zenker G
    Int J Clin Pharmacol Ther; 1997 Sep; 35(9):389-96. PubMed ID: 9314093
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combining ECG Criteria for Left Ventricular Hypertrophy Improves Risk Prediction in Patients With Hypertension.
    Okin PM; Hille DA; Kjeldsen SE; Devereux RB
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29151037
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Long term treatment of resistant hypertension with captopril (author's transl)].
    Guedon J; Chaignon M; Lucsko M; Cuche JL; Aubert P; Piete AM
    Nouv Presse Med; 1981 Apr; 10(19):1565-9. PubMed ID: 7025846
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regression of left ventricular hypertrophy and control of hypertension in the spontaneously hypertensive rat (SHR): oxprenolol versus hydrochlorothiazide.
    Idikio H; Fernandez PG; Triggle CR; Kim BK
    Clin Invest Med; 1983; 6(1):43-8. PubMed ID: 6219850
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence of left ventricular hypertrophy in elderly patients with well controlled hypertension.
    Jones E; Morgan TO; Califiore P; Johns J
    Clin Exp Pharmacol Physiol; 1990 Mar; 17(3):207-10. PubMed ID: 2140302
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Left Ventricular Hypertrophy in Hypertensive Athletes can be Reduced by Antihypertensive Medication Despite Continuing Intense Aerobic Exercise.
    Ketelhut S; Franz IW; Ketelhut RG
    High Blood Press Cardiovasc Prev; 2018 Dec; 25(4):385-390. PubMed ID: 30341642
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Arterial hypertension, left ventricular hypertrophy and arrhythmias].
    González Maqueda I
    Rev Esp Cardiol; 1991 Nov; 44(9):586-98. PubMed ID: 1723211
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Regression of hypertrophy of the left ventricle in hypertensive subjects treated with captopril].
    Lusiani L; Locatelli C; Visconti Prasca M; Forin G
    Cardiologia; 1985 Mar; 30(3):223-7. PubMed ID: 2933149
    [No Abstract]   [Full Text] [Related]  

  • 52. Relation of QT interval and QT dispersion to regression of echocardiographic and electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan Intervention For Endpoint Reduction (LIFE) study.
    Oikarinen L; Nieminen MS; Toivonen L; Viitasalo M; Wachtell K; Papademetriou V; Jern S; Dahlöf B; Devereux RB; Okin PM;
    Am Heart J; 2003 May; 145(5):919-25. PubMed ID: 12766755
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Electrocardiographic left ventricular hypertrophy regression induced by an angiotensin receptor blocker-based regimen in hypertensive patients with diabetes: data from the SARA study.
    Barrios V; Escobar C; Calderón A; Echarri R; Barrios S; Navarro-Cid J
    J Renin Angiotensin Aldosterone Syst; 2009 Sep; 10(3):168-73. PubMed ID: 19651760
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Long-term treatment with captopril in arterial hypertension complicated by renal failure].
    Durand D; Ader JL; Emal V; Bories P; Girolami JP; Suc JM
    Arch Mal Coeur Vaiss; 1982 Jun; 75 Spec No():151-6. PubMed ID: 6126168
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The importance of left ventricular hypertrophy in human hypertension.
    Kahan T
    J Hypertens Suppl; 1998 Sep; 16(7):S23-9. PubMed ID: 9855028
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of carvedilol on pulse pressure and left ventricular hypertrophy in spontaneously hypertensive rats with adriamycin nephropathy.
    Jovanovic D; Jovovic D; Mihailovic-Stanojevic N; Miloradovic Z; Naumovic R; Dimitrijevic J; Maksic N; Djukanovic L
    Biomed Pharmacother; 2009 Sep; 63(8):571-6. PubMed ID: 19013753
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of blood pressure changes on development and regression of electrocardiographic left ventricular hypertrophy: a 26 year longitudinal study.
    Ashizawa N; Seto S; Kitano K; Toyama K; Sasaki H; Kodama K; Hosoda Y; Shimaoka K; Shibata Y; Hashiba K
    J Am Coll Cardiol; 1989 Jan; 13(1):165-72. PubMed ID: 2521227
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term efficacy of angiotensin-converting-enzyme inhibition with captopril in mild-to-moderate essential hypertension.
    Stumpe KO; Overlack A; Kolloch R; Schreyer S
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):121S-126S. PubMed ID: 6291563
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of captopril on severe renin-dependent hypertension of uraemics on regular dialysis treatment.
    Pyrpasopoulos M; Sion M; Paraskevopoulos G; Zuruzoglu W; Paradelis AG
    Methods Find Exp Clin Pharmacol; 1983; 5(2):131-4. PubMed ID: 6348445
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Electrocardiographic characteristics and metabolic risk factors associated with inappropriately high left ventricular mass in patients with electrocardiographic left ventricular hypertrophy: the LIFE Study.
    Palmieri V; Okin PM; de Simone G; Bella JN; Wachtell K; Gerdts E; Boman K; Nieminen MS; Dahlöf B; Devereux RB
    J Hypertens; 2007 May; 25(5):1079-85. PubMed ID: 17414673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.